eConsent

To gain a deeper understanding of eConsent, we have gathered the 10 most frequently asked questions that address the complexities of adoption, integration, and compliance measures

At DTxEast 2023, Castor joined a panel discussion to answer big questions when designing DTx clinical trials

eConsent plays a pivotal role in optimizing modern clinical trials, but the nuance around its adoption for pharmaceutical and medical device companies remains a consideration for implementation teams.

In this blog we cover how eConsent benefits trials and aligns with IRB ethical commitments, how to prepare your IRB submission for approval, and the future impact of large language models on the informed consent process.

An avalanche of data from so many real-world sources is available today, with the promise of more data generated daily—so why not use it?

For successful decentralized clinical trials, researchers must encourage patient engagement. Learn 5 steps that modern companies are taking for better outcomes.

Each rare disease research breakthrough offers the promise of a longer, better life for patients who otherwise may…

Although eConsent struggled to gain momentum and wider acceptance pre-pandemic, it’s now a major part of clinical research. In this article, learn three ways eConsent addresses the requirements for valid informed consent.

Since it was first instituted in the 1960s, written consent to participate in research studies has undergone very little change other than tightening regulations and increased participant education of their rights.

eConsent accelerates enrollment, increases retention, and reduces site burden. Find out why it’s the way of the future for clinical trials here.